Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.

Journal of the European Academy of Dermatology and Venereology : JEADV - 1 Feb 2023

Pissa Maria, Lapins Jan, Sköldmark Christina, Helgadottir Hildur

Abstract excerpt

BACKGROUND: Inherited mutations in the CDKN2A gene are among the strongest known risk factors for cutaneous melanoma. Further, previous studies have reported inferior melanoma-specific survival in CDKN2A mutation carriers. OBJECTIVES: Here, the melanoma-specific survival was studied, depending on CDKN2A carrier status and if the melanomas had been diagnosed before or after families were included in a surveillance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Melanoma

Share to Melanoma, Cutaneous Malignant

Share to Mutation

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36156317
DOI: 10.1111/jdv.18589
PMCID: PMC10091727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.PMID 36156317Read ↗

Germline<i>CDKN2A</i>Mutation Status and Survival in Familial Melanoma CasesSemantic proximity Read ↗

CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.Semantic proximity Read ↗

Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.Semantic proximity Read ↗

Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers.Semantic proximity Read ↗

Temporal correlation between the first melanoma and the first noncutaneous tumor in CKDN2A genotyped patients.Semantic proximity Read ↗

Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.Semantic proximity Read ↗

Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.Semantic proximity Read ↗

Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry.Semantic proximity Read ↗

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.Semantic proximity Read ↗

Dermatologic surveillance in healthy carriers of CDKN2A and p.E318K MITF germline variants from melanoma-prone families: a 14 years hospital-based experience.Semantic proximity Read ↗

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.Semantic proximity Read ↗

Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.